Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.

A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT00105443 ·Status: COMPLETED ·Phase: PHASE3

Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer

NCT01042041 ·Status: COMPLETED ·Phase: PHASE1

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT01004978 ·Status: COMPLETED ·Phase: PHASE3

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

NCT04032860 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC

NCT01997957 ·Status: UNKNOWN ·Phase: PHASE4

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

NCT05311319 ·Status: UNKNOWN ·Phase: PHASE2

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

NCT06001567 ·Status: UNKNOWN ·Phase: PHASE2

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

NCT04676633 ·Status: COMPLETED ·Phase: PHASE1

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

NCT00077142 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

NCT01015833 ·Status: COMPLETED ·Phase: PHASE3

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

NCT05220722 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

NCT04135690 ·Status: UNKNOWN ·Phase: PHASE2

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

NCT03144661 ·Status: TERMINATED ·Phase: PHASE1

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy

NCT05630937 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Trial of TRC105 and Sorafenib in Patients With HCC

NCT02560779 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

NCT06418659 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

NCT02101593 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

NCT00073736 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

NCT00901901 ·Status: COMPLETED ·Phase: PHASE3

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

NCT00012324 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC

NCT06818097 ·Status: COMPLETED

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

NCT00843934 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

NCT00108953 ·Status: COMPLETED ·Phase: PHASE2

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

NCT03869034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

NCT00986661 ·Status: UNKNOWN ·Phase: PHASE1